| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a31fcdeefbdf9a5bc2f0367c32e013a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2017-10-10^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ba1376ac0b2b9b20bba9a07f221887d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce0658d5e60e9c6908f8216319633f33 |
| publicationDate |
2018-04-19^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018071404-A1 |
| titleOfInvention |
Inhibitors of mutant isocitrate dehydrogenases and compositions and methods thereof |
| abstract |
The invention provides novel chemical compounds useful for treating cancer, or a related disease or disorder thereof, and pharmaceutical composition and methods of preparation and use thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020001474-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3658563-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11407717-B2 |
| priorityDate |
2016-10-11^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |